Hollis-Eden Pharmaceuticals Prices $62.5 Million Follow-On Offering of...
09/26/2003
SAN DIEGO--(BUSINESS WIRE)--Sept. 26, 2003--Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced the pricing of its follow-on offering of
common stock. The Company has agreed to sell 2.5 million shares of its common stock at $25.00 per share. The Company has also granted an over-allotment
option to the underwriters to purchase up to an additional 375,000 shares of common stock. All of the shares are being sold by the Company.
The managing underwriters and joint book-running managers of this offering are Jefferies & Company, Inc. and SG Cowen Securities Corporation.
Hollis-Eden Pharmaceuticals, Inc. is a development-stage pharmaceutical company based in San Diego, California, engaged in the development of products
for the treatment of infectious diseases and immune system disorders.
The offering is expected to close on October 1, 2003, subject to the satisfaction of customary closing conditions.
A registration statement relating to these securities was filed with and has been declared effective by the Securities and Exchange Commission.
This press release shall not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in
any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Copies of the final prospectus may be obtained from Jefferies & Company, Inc. at 520 Madison Avenue, New York, New York 10022-4213, or from SG Cowen
Securities Corporation at 1221 Avenue of the Americas, New York, New York 10020.
News Room
04/23/2010 - Diamond Halpern Capital is Issuing Coverage of American Lorain Corp. |
|
03/18/2009 - Halpern Capital Announces Senior Investment Banking Hires |
|
02/06/2006 - ParkerVision Announces Private Placement of $17.8 Million |
|
10/05/2005 - NutraCea and RiceX Complete Merger |
|
04/19/2005 - Thomas Equipment Inc. Completes $25M Institutional Equity Raise and... |
|
06/17/2004 - Terremark Completes Sale of an Additional $11.25 Million of Convertible... |
|
12/30/2003 - 3D Systems Completes Private Placement of 6% Convertible Subordinated... |
|
09/26/2003 - Hollis-Eden Pharmaceuticals Prices $62.5 Million Follow-On Offering of... |
